Análisis de desarrollo de la cadena farmacéutica Distrifarma durante la Pandemia SARS-COV2.

Abstract

Pharmaceutical companies have always been part of a key economic and social sector for the proper distribution of medicines. At the time of the Covid-19 pandemic, worldwide, maintaining the supply and demand chain was difficult due to the shortage of medicines, both for products related to the SARS-COV2 virus, and those related to other conditions; in Ecuador the reality was no different. In this context, the pharmaceutical company Distrifarma is studied with the general objective of analyzing the economic development it has had during the SARS-COV2 pandemic. At the same time, it is expected to achieve the specific objectives of inquiring about the pharmaceutical sector and its management, identifying the public policies that regulate the pharmaceutical sector in Ecuador and proposing strategic changes for the post-pandemic period through a mixed methodology, through a mixed methodology, based on the documentary and interview technique in order to collect and analyze relevant information from the company's database, as well as being able to know its management with the interview of a non-probabilistic sample. The results indicate that the company had a great growth between the years 2019 and 2020 and that these profits were invested to ensure growth in the years to come.